by Nelsan Pourhadi, Amani Meaidi, Søren Friis, Christian Torp-Pedersen, Lina S. Mørch Background Use of estrogen-containing menopausal hormone therapy has been shown to influence the risk of central nervous system (CNS) tumors. However, it is unknown how the progestin-component affects the risk and whether continuous versus cyclic treatment regimens influence the risk differently. Methods and […]

Read More